Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 3, Pages 687
Publisher
MDPI AG
Online
2022-01-30
DOI
10.3390/cancers14030687
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of PARP1 in neurodegenerative diseases and aging
- (2021) Kanmin Mao et al. FEBS Journal
- Transcription-Coupled DNA Repair: From Mechanism to Human Disorder
- (2021) Diana van den Heuvel et al. TRENDS IN CELL BIOLOGY
- PARP-DNA trapping ability of PARP inhibitors jeopardizes astrocyte viability: Implications for CNS disease therapeutics
- (2021) Asha Sinha et al. NEUROPHARMACOLOGY
- Targeting Parthanatos in Ischemic Stroke
- (2021) Raymond C. Koehler et al. Frontiers in Neurology
- ADP‐ribosyltransferases, an update on function and nomenclature
- (2021) Bernhard Lüscher et al. FEBS Journal
- Structure-based design, synthesis, and evaluation of inhibitors with high selectivity for PARP-1 over PARP-2
- (2021) Jiang Yu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination
- (2021) Yan Wang et al. Cell Reports
- Microglial NMDA receptors drive pro‐inflammatory responses via PARP‐1/TRMP2 signaling
- (2020) Prajwal Raghunatha et al. GLIA
- X‐linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies
- (2020) Bela R. Turk et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Fingolimod rescues demyelination in a mouse model of Krabbe's disease
- (2020) Sibylle Béchet et al. JOURNAL OF NEUROSCIENCE
- Dopaminergic Control over the Tripartite Synapse
- (2020) Jeroen P.H. Verharen et al. NEURON
- Delayed PARP-1 Inhibition Alleviates Post-stroke Inflammation in Male Versus Female Mice: Differences and Similarities
- (2020) Jian Chen et al. Frontiers in Cellular Neuroscience
- Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer’s Disease
- (2020) Felipe Salech et al. Frontiers in Aging Neuroscience
- The Nucleolus and PARP1 in Cancer Biology
- (2020) Marina Engbrecht et al. Cancers
- Poly(ADP-ribose) polymerase inhibition: past, present and future
- (2020) Nicola J. Curtin et al. NATURE REVIEWS DRUG DISCOVERY
- PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
- (2020) Maddison Rose et al. Frontiers in Cell and Developmental Biology
- Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins
- (2019) Elizaveta E Alemasova et al. NUCLEIC ACIDS RESEARCH
- Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy
- (2019) Caroline G. Bergner et al. GLIA
- Microglia-mediated neuroinflammation in neurodegenerative diseases
- (2019) Charannya Sozheesvari Subhramanyam et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Molecular Control of Oligodendrocyte Development
- (2019) Benayahu Elbaz et al. TRENDS IN NEUROSCIENCES
- Diagnosis, prognosis, and treatment of leukodystrophies
- (2019) Marjo S van der Knaap et al. LANCET NEUROLOGY
- The Role of PARPs in Inflammation—and Metabolic—Related Diseases: Molecular Mechanisms and Beyond
- (2019) Ke et al. Cells
- PARP Inhibition in Cancer: An Update on Clinical Development
- (2019) Esha Sachdev et al. Targeted Oncology
- PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
- (2019) Sylvie M. Noordermeer et al. TRENDS IN CELL BIOLOGY
- An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies
- (2019) Mahmoud Reza Ashrafi et al. Expert Review of Neurotherapeutics
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- (2019) Jerry H. Houl et al. Nature Communications
- Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases
- (2019) Simonetta Pazzaglia et al. Cells
- Inhibition of poly(ADP-ribose) polymerase-1 alters expression of mitochondria-related genes in PC12 cells: relevance to mitochondrial homeostasis in neurodegenerative disorders
- (2018) Grzegorz A. Czapski et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Impaired plasticity of macrophages in X-linked adrenoleukodystrophy
- (2018) Isabelle Weinhofer et al. BRAIN
- Astrocytes, neurons, synapses: a tripartite view on cortical circuit development
- (2018) Isabella Farhy-Tselnicker et al. Neural Development
- Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance
- (2018) Jone Michelena et al. Nature Communications
- Cancer Imprints an Increased PARP-1 and p53-Dependent Resistance to Oxidative Stress on Lymphocytes of Patients That Later Develop Alzheimer's Disease
- (2018) Felipe Salech et al. Frontiers in Neuroscience
- The comings and goings of PARP-1 in response to DNA damage
- (2018) John M. Pascal DNA REPAIR
- Persistent accumulation of unrepaired DNA damage in rat cortical neurons: nuclear organization and ChIP-seq analysis of damaged DNA
- (2018) Jorge Mata-Garrido et al. Acta Neuropathologica Communications
- Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
- (2018) Tae-In Kam et al. SCIENCE
- PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway
- (2017) Eniko Hocsak et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mechanical plasticity during oligodendrocyte differentiation and myelination
- (2017) Helena S. Domingues et al. GLIA
- PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
- (2017) Luyao Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adult Glioblastoma
- (2017) Brian M. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease
- (2017) Karim Gariani et al. JOURNAL OF HEPATOLOGY
- Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma
- (2017) Sani H. Kizilbash et al. MOLECULAR CANCER THERAPEUTICS
- The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
- (2017) Arnab Ray Chaudhuri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Poly(ADP-ribose) polymerase-1 regulates microglia mediated decrease of endothelial tight junction integrity
- (2017) Abbas Rezaeian Mehrabadi et al. NEUROCHEMISTRY INTERNATIONAL
- PARP activity and inhibition in fetal and adult oligodendrocyte precursor cells: Effect on cell survival and differentiation
- (2017) Vito A. Baldassarro et al. Stem Cell Research
- PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma
- (2017) Balázs Murnyák et al. Oncotarget
- Oligodendroglial myelination requires astrocyte-derived lipids
- (2017) Nutabi Camargo et al. PLOS BIOLOGY
- The PARP family: insights into functional aspects of poly (ADP-ribose) polymerase-1 in cell growth and survival
- (2016) T. Jubin et al. CELL PROLIFERATION
- An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy
- (2016) Ying-Qing Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier
- (2016) Slava Rom et al. Journal of Neuroinflammation
- Krabbe disease: One Hundred years from the bedside to the bench to the bedside
- (2016) David A. Wenger et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Clinical management of Krabbe disease
- (2016) Maria L. Escolar et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Gene therapy for metachromatic leukodystrophy
- (2016) Jonathan B. Rosenberg et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia
- (2016) Fei Teng et al. NEUROCHEMICAL RESEARCH
- Cultured networks of excitatory projection neurons and inhibitory interneurons for studying human cortical neurotoxicity
- (2016) Jin-Chong Xu et al. Science Translational Medicine
- Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy
- (2016) Kathryn A. Thibert et al. Scientific Reports
- Dynamics and Mechanisms of CNS Myelination
- (2015) Kathryn K. Bercury et al. DEVELOPMENTAL CELL
- Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling
- (2015) C. O'Sullivan et al. JOURNAL OF CELL SCIENCE
- Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy
- (2015) Gianluca Papeo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Delineation ofMGMTHypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
- (2015) Shiv K. Gupta et al. JNCI-Journal of the National Cancer Institute
- Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System
- (2015) K. E. Parrish et al. MOLECULAR CANCER THERAPEUTICS
- Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
- (2015) Felix Y. Feng et al. MOLECULAR CELL
- Anti-inflammatory Therapy With Simvastatin Improves Neuroinflammation and CNS Function in a Mouse Model of Metachromatic Leukodystrophy
- (2015) Axel Stein et al. MOLECULAR THERAPY
- Astrocitos en las enfermedades neurodegenerativas (I): función y caracterización molecular
- (2015) T. Guillamón-Vivancos et al. NEUROLOGIA
- Poly(ADP-ribose) polymerase 1 is a novel target to promote axonal regeneration
- (2015) Camille Brochier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delineation ofMGMTHypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
- (2015) Shiv K. Gupta et al. JNCI-Journal of the National Cancer Institute
- Microglia Development and Function
- (2014) Debasis Nayak et al. Annual Review of Immunology
- X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment
- (2014) Marc Engelen et al. Current Neurology and Neuroscience Reports
- Transcriptional Roles of PARP1 in Cancer
- (2014) Matthew J. Schiewer et al. MOLECULAR CANCER RESEARCH
- PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca2+-permeable AMPA receptors
- (2014) E. Gerace et al. NEUROBIOLOGY OF DISEASE
- Targeting poly(ADP-ribose)polymerase1 in neurological diseases: A promising trove for new pharmacological interventions to enter clinical translation
- (2014) Chandra Shekhar Sriram et al. NEUROCHEMISTRY INTERNATIONAL
- PARP1 activation/expression modulates regional-specific neuronal and glial responses to seizure in a hemodynamic-independent manner
- (2014) J-E Kim et al. Cell Death & Disease
- PARP1 enhances inflammatory cytokine expression by alteration of promoter chromatin structure in microglia
- (2014) Ricardo Iván Martínez-Zamudio et al. Brain and Behavior
- Pathophysiology of X-linked adrenoleukodystrophy
- (2013) J. Berger et al. BIOCHIMIE
- Parp-2 is required to maintain hematopoiesis following sublethal -irradiation in mice
- (2013) J. Farres et al. BLOOD
- PARP-1 Inhibition Attenuates Neuronal Loss, Microglia Activation and Neurological Deficits after Traumatic Brain Injury
- (2013) Bogdan A. Stoica et al. JOURNAL OF NEUROTRAUMA
- PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage
- (2013) Sara Martire et al. PLoS One
- PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?
- (2013) Amanda Swindall et al. Cancers
- Structural Implications for Selective Targeting of PARPs
- (2013) Jamin D. Steffen et al. Frontiers in Oncology
- Zn2+-induced ERK activation mediates PARP-1-dependent ischemic-reoxygenation damage to oligodendrocytes
- (2012) Maria Domercq et al. GLIA
- Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor
- (2012) Joana C d’Avila et al. Journal of Neuroinflammation
- Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession
- (2012) Dong Liu et al. NEUROBIOLOGY OF AGING
- Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator
- (2012) Federica Laudisi et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase
- (2011) F Moroni et al. BRITISH JOURNAL OF PHARMACOLOGY
- PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity
- (2011) Leonardo Cavone et al. Multiple Sclerosis Journal
- Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?
- (2011) Leonardo Cavone et al. TRENDS IN MOLECULAR MEDICINE
- Ca2+ Permeable AMPA Channels in Diseases of the Nervous System
- (2011) John H. Weiss Frontiers in Molecular Neuroscience
- Temozolomide: Mechanisms of Action, Repair and Resistance
- (2011) Jihong Zhang et al. Current Molecular Pharmacology
- Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death
- (2010) S. Veto et al. BRAIN
- Pathomechanisms Underlying X-Adrenoleukodystrophy: A Three-Hit Hypothesis
- (2010) Inderjit Singh et al. BRAIN PATHOLOGY
- Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
- (2010) John K. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- NAD+ Depletion Is Necessary and Sufficient forPoly(ADP-Ribose) Polymerase-1-Mediated Neuronal Death
- (2010) C. C. Alano et al. JOURNAL OF NEUROSCIENCE
- Metachromatic Leukodystrophy – An Update
- (2010) V. Gieselmann et al. NEUROPEDIATRICS
- PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats
- (2009) E. Bartha et al. CARDIOVASCULAR RESEARCH
- Metachromatic leukodystrophy - mutation analysis provides further evidence of genotype-phenotype correlation
- (2009) A Biffi et al. CLINICAL GENETICS
- PARP inhibitors: New partners in the therapy of cancer and inflammatory diseases
- (2009) Andreína Peralta-Leal et al. FREE RADICAL BIOLOGY AND MEDICINE
- Astrocytic poly(ADP-ribose) polymerase-1 activation leads to bioenergetic depletion and inhibition of glutamate uptake capacity
- (2009) Kim San Tang et al. GLIA
- PolyADP-ribosylation is required for long-term memory formation in mammals
- (2009) Shmuel Goldberg et al. JOURNAL OF NEUROCHEMISTRY
- From Form to Function: the Ways to Know a Neuron
- (2009) Ian A. Meinertzhagen et al. JOURNAL OF NEUROGENETICS
- Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines
- (2009) M. J. Clarke et al. MOLECULAR CANCER THERAPEUTICS
- Poly (ADP-ribose) polymerases (PARPs) 1-3 regulate astrocyte activation
- (2008) Nirmal K. Phulwani et al. JOURNAL OF NEUROCHEMISTRY
- Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau
- (2008) K. N. Green et al. JOURNAL OF NEUROSCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now